Improvement of verbal fluency in Alzheimer's disease after NADH treatment

被引：0

作者：

Demarin, V ^{[1
]}

Storga-Tomic, D ^{[1
]}

Bosnar-Puretic, M ^{[1
]}

Martinic-Popovic, I ^{[1
]}

Birkmayer, J ^{[1
]}

机构：

[1] Univ Zagreb, Sestre Milosrdnice Univ Hosp, Dept Neurol, Zagreb 41000, Croatia

来源：

PROCEEDINGS OF THE 7TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY | 2004年

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A loss of short-term memory and verbal fluency is often among first signs of the Alzheimer's disease (AD). The aim of the study was to investigate the influence of NADH treatment on memory and verbal fluency. This was a six-months, randomized, double blind, placebo controlled study. AD patients with MMSE between 10 and 25 were included. We compared results of Mattis Dementia Rating Scale (MDRS), Hopkins Verbal Learning Test and the Verbal Fluency Test performed at the baseline and after six months of treatment. We enrolled 48 patients, median age of 69 years. After six months of treatment NADH group showed improvement in Verbal Fluency Test for 3.5 words per minute, while placebo group experienced decrease for 0.5 words per minute (p=0.05). Similar result revealed verbal fluency testing included in MDRS (p<0.05). Memory testing also revealed results for the benefit of the NADH treatment, but they weren't statistically significant (Hopkins Verbal Learriing Test, p>0.05; MDRS, p>0.05). During the NADH treatment greater influence on verbal fluency than on memory was observed.

引用

页码：41 / 45

页数：5

共 17 条

[11] A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE [J].

KNAPP, MJ ;

KNOPMAN, DS ;

SOLOMON, PR ;

PENDLEBURY, WW ;

DAVIS, CS ;

GRACON, SI ;

APTER, JT ;

LAZARUS, CN ;

BAKER, KE ;

BARNETT, M ;

BAUMEL, B ;

EISNER, LS ;

CASTELLS, B ;

BOLOURI, R ;

BENNETT, D ;

FORCHETTI, C ;

LEVIN, A ;

BLASS, JP ;

NOLAN, KA ;

GAINES, ER ;

RELKIN, N ;

BORISON, RL ;

DIAMOND, B ;

CELESIA, GG ;

ROSS, AP ;

DEXTER, J ;

DOODY, R ;

LIPSCOMB, L ;

KREITER, K ;

DUBOFF, EA ;

BLOCK, P ;

MARSHALL, D ;

WESTERGAARD, N ;

EARL, NL ;

WYNE, SV ;

HINMANSMITH, E ;

FARLOW, M ;

HENDRIE, HC ;

CARESS, JA ;

FARMER, M ;

HARPER, JE ;

FERGUSON, J ;

FOSTER, NL ;

BARBAS, NR ;

BLUEMLEIN, LA ;

GELB, DJ ;

BERENT, S ;

GIORDANI, B ;

GREENWALD, M ;

BERGMAN, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :985-991

[12] NEUROPSYCHOLOGICAL EFFECTS OF L-DEPRENYL IN ALZHEIMERS TYPE DEMENTIA [J].

PICCININ, GL ;

FINALI, G ;

PICCIRILLI, M .

CLINICAL NEUROPHARMACOLOGY, 1990, 13 (02) :147-163

[13] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].

Rogers, SL ;

Farlow, MR ;

Doody, RS ;

Mohs, R ;

Friedhoff, LT ;

Albala, B ;

Baumel, B ;

Booker, G ;

Dexter, J ;

Farmer, M ;

Feighner, JP ;

Ferris, S ;

Gordon, B ;

Gorman, DG ;

Hanna, G ;

Harrell, LE ;

Hubbard, R ;

Kennedy, J ;

McCarthy, J ;

Scharre, DW ;

Schaerf, F ;

Schneider, L ;

Seltzer, B ;

Siegal, A ;

Stark, SR ;

Strauss, A ;

Walshe, TM .

NEUROLOGY, 1998, 50 (01) :136-145

[14] Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients [J].

Storga, D ;

Vrecko, K ;

Birkmayer, JGD ;

Reibnegger, G .

NEUROSCIENCE LETTERS, 1996, 203 (01) :29-32

[15]

Stryer L., 1981, BIOCHEMISTRY-US

[16]

Victor M, 2001, ADAMS VICTORS PRINCI

[17] NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells [J].

Vrecko, K ;

Storga, D ;

Birkmayer, JGD ;

Moller, R ;

Tafeit, E ;

Horejsi, R ;

Reibnegger, G .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (01) :59-65

← 1 2 →